By allowing ads to appear on this site, you support the local businesses who, in turn, support great local journalism.
Northside Forsyth offers new technology to screen for rare cancer
Northside

Doctors within the tallest building in Forsyth County have reached higher heights in diagnosing and treating a rare form of cancer.

The U.S. Food and Drug Administration recently approved a product called NETSPOT, which is used in the preparation of Gallium-68 (Ga-68) dotatate for positron emission tomography – computer tomography (PET/CT) imaging that helps doctors find neuroendocrine tumors (NETs) easier and earlier, and the Northside Hospital Cancer Institute is one of only a handful in the Southeast to offer it.

NETSPOT is available at Northside imaging centers in Cumming, Atlanta, Decatur, Fayetteville and Lawrenceville.

Most NETs are not harmful – more than 12,000 people in the United States are diagnosed with NETs each year, according to the Neuroendocrine Tumor Research Foundation. They develop in the hormone-producing cells of the body’s neuroendocrine system and often form in the intestine, pancreas or lungs.

Sometimes, however, they trigger a rare form of cancer than can be difficult with current imaging techniques.

Until now.

“NETSPOT provides a more sensitive and specific imaging tool to determine location of disease, for staging and restaging of patients with well-differentiated and moderately differentiated NETs,” said William C. Lavely, a nuclear medicine specialist at Northside Radiology Associates.

Ga-68 dotatate is a radioactive diagnostic agent that is specifically designed to detect somatostatin receptors, including those in NETs. When injected into a patient, the agent binds to the receptors.

“Somatostatin is a hormone that regulates the endocrine system and is expressed by neuroendocrine cells,” Lavely said. “This provides a unique target for neuroendocrine tumor imaging.”

Combined with PET/CT imaging, which offers higher resolution, 3D and more rapid imaging than other technologies, NETSPOT gives doctors a better picture of the disease and what they have to treat.

“Patients who are diagnosed with NETs early,” Lavely said, “have a better chance of beating or managing the disease.”